TRIP11 and prostate carcinoma: This suggests that loss of Rb in CRPC contributes to the progression and lethality of the disease and that cellular transformation through the Rb-TRIP230-HIF1 complex is not just a function of hormone-sensitive or early stage prostate cancers.